Ads
-
Related paper
- Revacept: Collagen GP VI receptor inhibitor, a new & a formidable target for antiplatelet action
- In silico identification of promising inhibitor against RNA-dependent RNA polymerase target of SARS-CoV-2
- Cannabinoid Receptor CB2 Subtype: A Novel Pharmacological Target in Cancer and Neurodegenerative Diseases
- The Dopamine Receptor D1(DRD1) as Target for Developinga Therapy for Cocaine Addiction |Biomedgrid
- Neopterin - inhibitor of dihydrofolate reductase and hypothetical action in the human body
- Aluminum in Reaction with Sodium Hydroxide: Summary Action of a Depolarizer and an Inhibitor
- In silico miRNA Target Identification within the Human Peroxisome Proliferator -Activated Receptor Gamma (PPARG) Gene
- MOLECULAR DOCKING STUDIES OF PHYTOCHEMICALS OF VITEX NEGUNDO (L) AGAINST ADENOSINE A1 RECEPTOR AS THERAPEUTIC TARGET IN CARDIOVASCULAR DISEASES
- Structural Properties Study and Spectroscopic (FT-IR and UV-Vis) Profiling of the Novel Antagonist LY2157299 as a Transforming Growth Factor-β (TGF-β) Receptor I Kinase Inhibitor by Quantum-mechanical (QM) and Molecular Docking Techniques
- In Silico Estrogen Receptor Activity Evaluation of Some β-Carboline Derivatives Through Molecular Docking Approach and Target Prediction by ADME Study